 
     +86-15801534258
            +86-15801534258
         info@nebulabio.cn
            info@nebulabio.cn
         
                    
                    
                | Product Name | NebuSelect™ Recombinant Human LRRC15/LIB, Avi-His-tag | 
|---|---|
| Catalog Number | NBL-240472 | 
| Alias/Synonyms | LRRC15/LIB; LIB; LRRC15 | 
| Appearance | see COA | 
| Molecule Weight | |
| CAS | N/A | 
| Solubility | Water Soluble | 
| Storage | Short term 4℃; Long term -20℃. | 
| Shelf Life | 2 years | 
| Additional info 1 | Q8TF66-1 | 
| Additional info 2 | 
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-240472-100ug | 100ug | Inquire | Inquire | |
| NBL-240472-1mg | 1mg | Inquire | Inquire | |
| NBL-240472-Customized Size | N/A | Inquire | Inquire | 
    
Product Name:
NebuSelect™ Recombinant Human LRRC15/LIB, Avi-His-tag
    
Catalog#:
NBL-240472
    
Description:
NebuSelect™ Recombinant Human LRRC15/LIB, Avi-His-tag(Cat#NBL-240472) is expressed in CHO with His tag and Avi tag at the C-Terminus.It contains Tyr22-Gly538.
    
Species:
Human
    
Expression System:
CHO
    
Molecular Weight:
The protein has a predicted MW of 60.7 kDa. Due to glycosylation, the protein migrates to 70-80 kDa based on Bis-Tris PAGE result.
    
Target Name:
LRRC15/LIB; LIB; LRRC15
    
    Target Information:
The chimeric protein binds in vitro and in vivo to a specific element upstream of LRRC15, leading to dramatic transcriptional activation.- LRRC15 encodes a leucine-rich transmembrane protein, present at the leading edge of migrating cells, the expression of which in normal tissues is restricted to the invasive cytotrophoblast layer of the placenta; small interfering (siRNA)-mediated suppression of LRRC15 expression in breast cancer cells leads to abrogation of invasiveness in vitro.
    
Amino Acid Sequence:
    
Purity:
>95%
    
Formulation:
see COA
    
Endotoxin:
<1EU/ug(LAL Method)
    
Storage:
4°C for short term.
-20°C for long term.
    
To get more information, please contact us freely.